Abstract
Knowledge about the natural history of type 2 diabetes (T2D) with a preclinical phase, modifiable risk factors, an effective and simple screening tool to identify high-risk subjects and effective intervention that is affordable and acceptable are necessary. In addition, the efficacy of the intervention has to be proven in a clinical trial setting. Such proof for lifestyle prevention of T2D from randomised clinical trials has accumulated as several major lifestyle intervention trials have been successfully carried out. The results are consistent: the risk of T2D in high-risk subjects can be halved; the effect of lifestyle changes is rapid; the magnitude of lifestyle changes required to achieve a significant risk reduction does not have to be drastic, and benefits are similar in different ethnic groups.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
